Is the second jab of an anti-SARS-CoV-2 vaccine reasonable after guillain-Barre syndrome following the first dose?
Indian J Public Health
; 66(3): 385-386, 2022.
Article
in English
| MEDLINE | ID: covidwho-2055730
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Guillain-Barre Syndrome
/
COVID-19
Topics:
Vaccines
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Indian J Public Health
Year:
2022
Document Type:
Article
Affiliation country:
Ijph.ijph_106_22
Similar
MEDLINE
...
LILACS
LIS